Search results
Kymera's (KYMR) Partner SNY to Expand Ongoing HS and AD Studies
Zacks via Yahoo Singapore Finance· 15 hours agoKymera Therapeutics, Inc. KYMR announced that partner Sanofi SNY intends to rapidly expand the...
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo Singapore Finance· 2 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Kymera Therapeutics soars as Sanofi expands phase 2 trials
Investing.com via Yahoo Singapore Finance· 13 hours agoInvesting.com - Kymera Therapeutics Inc , (NASDAQ:KYMR) a clinical-stage biopharmaceutical firm specializing in the development of novel small molecule medicines using targeted protein degradation ...
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Zacks via Yahoo Singapore Finance· 7 days agoRegeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic...
Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
Benzinga via Yahoo Singapore Finance· 7 days ago(EMA) approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with uncontrolled...
Bpifrance eyes investment in Sanofi's consumer health business
Reuters via Yahoo Singapore Finance· 6 days agoThe French public investment bank is in talks with "many funds" and may team up with the winning bidder for Sanofi's consumer health unit, Gonzalo was quoted as saying. Bpifrance ...
FTC Chair Khan slams PBMs for higher drug prices in an interim report on the industry
Yahoo Finance· 11 hours agoThe FTC released a much-anticipated interim report without taking any action. It comes as the Biden...
Bénéteau And Two Other Leading Dividend Stocks On Euronext Paris
Simply Wall St. via Yahoo Singapore Finance· 23 hours agoAmidst a backdrop of political shifts and economic uncertainties across Europe, France's market has...
Assured Guaranty, Kymera rise; BP, Helen of Troy fall, Tuesday, 7/9/2024
Associated Press via Yahoo Singapore Finance· 13 hours agoThe technology company announced plans for a sale of up to $125 million in stock. Kymera Therapeutics Inc., up $7.48 to $39.44. The biopharmaceutical company's partner, Sanofi
Three Solid Euronext Paris Dividend Stocks With Yields Up To 7.9%
Simply Wall St. via Yahoo Singapore Finance· 5 days agoAmidst a backdrop of political uncertainty and rising bond yields in France, investors are closely...